A phase II trial of etoposide and cisplatin in the treatment of recurrent ependymomas.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Etoposide
- Indications Ependymoma
- Focus Therapeutic Use
- 11 May 2011 Biomarkers information updated
- 12 Jul 2010 Actual end date (Jan 2005) added as reported by ClinicalTrials.gov.
- 12 Jul 2010 Additional lead trial investigator identified as reported by ClinicalTrials.gov.